• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pathology, clinical presentations, and outcomes of C1q nephropathy.C1q肾病的病理学、临床表现及预后
J Am Soc Nephrol. 2008 Nov;19(11):2237-44. doi: 10.1681/ASN.2007080929. Epub 2008 Jul 23.
2
Clinicopathologic correlation and outcome of C1q nephropathy.C1q肾病的临床病理相关性及预后
Clin J Am Soc Nephrol. 2008 Nov;3(6):1637-43. doi: 10.2215/CJN.00830208. Epub 2008 Jul 23.
3
C1q nephropathy: a variant of focal segmental glomerulosclerosis.C1q肾病:局灶节段性肾小球硬化的一种变异型。
Kidney Int. 2003 Oct;64(4):1232-40. doi: 10.1046/j.1523-1755.2003.00218.x.
4
C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome?C1q肾病:C1q沉积在肾病综合征中是否具有任何预后意义?
Nephrol Dial Transplant. 1992;7(5):391-6.
5
Clinicopathologic correlation of C1q nephropathy in children.儿童C1q肾病的临床病理相关性
Am J Kidney Dis. 2006 Mar;47(3):412-8. doi: 10.1053/j.ajkd.2005.11.013.
6
The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.局灶节段性肾小球硬化的非特异性。原发性局灶性肾小球硬化的定义特征、系膜增生和微小病变。
Medicine (Baltimore). 1997 Jan;76(1):42-52. doi: 10.1097/00005792-199701000-00004.
7
Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan.巴基斯坦成人肾病综合征患者肾小球肾炎的谱系
Clin Exp Nephrol. 2009 Feb;13(1):38-43. doi: 10.1007/s10157-008-0075-0. Epub 2008 Aug 7.
8
IgM nephropathy in India: a single centre experience.印度的 IgM 肾病:单中心经验。
Indian J Pediatr. 2012 Aug;79(8):1025-7. doi: 10.1007/s12098-012-0693-0.
9
C1Q nephropathy in children.儿童C1Q肾病
Pediatr Nephrol. 2005 Dec;20(12):1756-61. doi: 10.1007/s00467-005-2040-4. Epub 2005 Oct 25.
10
C1q nephropathy: features at presentation and outcome.C1q肾病:临床表现及预后特征
Pediatr Nephrol. 2005 Jun;20(6):744-9. doi: 10.1007/s00467-004-1810-8. Epub 2005 Apr 13.

引用本文的文献

1
A Mycophenolic Acid Concentration-Time Curve (0-12 Hours) to Maintain Remission Without Recurrent Infection in C1q Nephropathy: A Case Report.维持C1q肾病缓解且无反复感染的霉酚酸浓度-时间曲线(0 - 12小时):一例报告
Cureus. 2025 Jul 8;17(7):e87544. doi: 10.7759/cureus.87544. eCollection 2025 Jul.
2
Immunofluorescence Use and Techniques in Glomerular Diseases: A Review.肾小球疾病中免疫荧光的应用与技术:综述
Glomerular Dis. 2024 Nov 11;4(1):227-240. doi: 10.1159/000542497. eCollection 2024 Jan-Dec.
3
Endocapillary proliferative glomerulonephritis associated with Q fever endocarditis: A case report.与Q热心内膜炎相关的毛细血管内增生性肾小球肾炎:一例报告
Clin Case Rep. 2024 Oct 21;12(10):e9473. doi: 10.1002/ccr3.9473. eCollection 2024 Oct.
4
Pediatric Bilateral Hypoplastic Kidney Complicated With C1q Nephropathy: A Case Report.小儿双侧肾发育不全合并C1q肾病:一例报告
Cureus. 2024 Jul 5;16(7):e63923. doi: 10.7759/cureus.63923. eCollection 2024 Jul.
5
The role of complement in kidney disease.补体在肾脏疾病中的作用。
Nat Rev Nephrol. 2023 Dec;19(12):771-787. doi: 10.1038/s41581-023-00766-1. Epub 2023 Sep 21.
6
A clinicopathological and prognostic study of 18 children with C1q nephropathy and focal segmental glomerulosclerosis: an 18-year experience from a single center.18 例 C1q 肾病和局灶节段性肾小球硬化患儿的临床病理和预后研究:单中心 18 年经验
J Nephrol. 2023 Jul;36(6):1615-1625. doi: 10.1007/s40620-023-01679-9. Epub 2023 Jul 10.
7
The appearance of C1q deposition in transplanted kidney allografts and its clinical and histopathologic features.移植肾同种异体移植物中C1q沉积的表现及其临床和组织病理学特征。
Korean J Transplant. 2022 Sep 30;36(3):180-186. doi: 10.4285/kjt.22.0032. Epub 2022 Aug 19.
8
C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes.肾病综合征患儿的C1q肾病:治疗策略与结局
Indian J Nephrol. 2022 Jan-Feb;32(1):54-59. doi: 10.4103/ijn.IJN_578_20. Epub 2021 Nov 13.
9
An Interesting Case of Nonlupus Full-House Nephropathy.一例非狼疮性全谱肾病的有趣病例。
Case Rep Nephrol. 2021 Dec 28;2021:9043003. doi: 10.1155/2021/9043003. eCollection 2021.
10
Proteomic analysis of machine perfusion solution from brain dead donor kidneys reveals that elevated complement, cytoskeleton and lipid metabolism proteins are associated with 1-year outcome.机器灌注液中蛋白质组学分析显示,脑死亡供肾中补体、细胞骨架和脂质代谢蛋白水平升高与 1 年预后相关。
Transpl Int. 2021 Sep;34(9):1618-1629. doi: 10.1111/tri.13984.

本文引用的文献

1
A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases.一种提议的足细胞病分类法:对原发性肾病的重新评估。
Clin J Am Soc Nephrol. 2007 May;2(3):529-42. doi: 10.2215/CJN.04121206. Epub 2007 Apr 11.
2
Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.局灶节段性肾小球硬化病理变异型的临床和病理特征
Kidney Int. 2006 Mar;69(5):920-6. doi: 10.1038/sj.ki.5000160.
3
Clinicopathologic correlation of C1q nephropathy in children.儿童C1q肾病的临床病理相关性
Am J Kidney Dis. 2006 Mar;47(3):412-8. doi: 10.1053/j.ajkd.2005.11.013.
4
C1Q nephropathy in children.儿童C1Q肾病
Pediatr Nephrol. 2005 Dec;20(12):1756-61. doi: 10.1007/s00467-005-2040-4. Epub 2005 Oct 25.
5
C1q nephropathy with asymptomatic urine abnormalities.伴有无症状性尿液异常的C1q肾病
Pediatr Nephrol. 2005 Nov;20(11):1669-70. doi: 10.1007/s00467-005-2024-4. Epub 2005 Aug 16.
6
C1q nephropathy: features at presentation and outcome.C1q肾病:临床表现及预后特征
Pediatr Nephrol. 2005 Jun;20(6):744-9. doi: 10.1007/s00467-004-1810-8. Epub 2005 Apr 13.
7
Distinguishing C1q nephropathy from lupus nephritis.鉴别C1q肾病与狼疮性肾炎。
Nephrol Dial Transplant. 2004 Jun;19(6):1420-6. doi: 10.1093/ndt/gfh139. Epub 2004 Mar 5.
8
C1q nephropathy: a variant of focal segmental glomerulosclerosis.C1q肾病:局灶节段性肾小球硬化的一种变异型。
Kidney Int. 2003 Oct;64(4):1232-40. doi: 10.1046/j.1523-1755.2003.00218.x.
9
C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis.表现为快速进展性新月体性肾小球肾炎的C1q肾病。
Pediatr Nephrol. 2000 Sep;14(10-11):976-9. doi: 10.1007/s004670050056.
10
Spontaneous improvement in a case of C1q nephropathy.1例C1q肾病的自发缓解
Am J Kidney Dis. 2000 May;35(5):E22. doi: 10.1016/s0272-6386(00)70287-3.

C1q肾病的病理学、临床表现及预后

Pathology, clinical presentations, and outcomes of C1q nephropathy.

作者信息

Vizjak Alenka, Ferluga Dusan, Rozic Mojca, Hvala Anastazija, Lindic Jelka, Levart Tanja Kersnik, Jurcić Vesna, Jennette J Charles

机构信息

Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia.

出版信息

J Am Soc Nephrol. 2008 Nov;19(11):2237-44. doi: 10.1681/ASN.2007080929. Epub 2008 Jul 23.

DOI:10.1681/ASN.2007080929
PMID:18650484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2573004/
Abstract

C1q nephropathy is an uncommon glomerular disease with characteristic features on immunofluorescence microscopy. In this report, clinicopathologic correlations and outcomes are presented for 72 patients with C1q nephropathy. The study comprised 82 kidney biopsies from 28 children and 54 adults with male preponderance (68%). Immunofluorescence microscopy showed dominant or co-dominant staining for C1q in the mesangium and occasional glomerular capillary walls. Electron-dense deposits were observed in 48 of 53 cases. Light microscopy revealed no lesions (n = 27), focal segmental glomerulosclerosis (FSGS; n = 11), proliferative glomerulonephritis (n = 20), or various other lesions (n = 14). Clinical presentations in the patients who had no lesions histology were normal urine examination (7%), asymptomatic hematuria and/or proteinuria (22%), and nephrotic syndrome (minimal change-like lesion; 63%), which frequently relapsed. All patients with FSGS presented with nephrotic syndrome. Those with proliferative glomerulonephritis usually presented with chronic kidney disease (75%) or asymptomatic urine abnormalities (20%). Of the patients with sufficient follow-up data, complete remission of the nephrotic syndrome occurred in 77% of those with a minimal change-like lesion, progression to end-stage renal disease occurred in 33% of those with FSGS, and renal disease remained stable in 57% of those with proliferative glomerulonephritis. In conclusion, this study identified two predominant clinicopathologic subsets of C1q nephropathy: (1) Podocytopathy with a minimal change-like lesion or FSGS, which typically presents with nephrotic syndrome, and (2) a typical immune complex-mediated glomerular disease that varies from no glomerular lesions to diverse forms of glomerular proliferation, which typically presents as chronic kidney disease. Clinical presentation, histology, outcomes, and presumably pathogenesis of C1q nephropathy are heterogeneous.

摘要

C1q肾病是一种罕见的肾小球疾病,在免疫荧光显微镜下具有特征性表现。在本报告中,呈现了72例C1q肾病患者的临床病理相关性及预后情况。该研究包括对28名儿童和54名成年人(男性占优势,68%)的82份肾活检标本。免疫荧光显微镜显示系膜区C1q呈显性或共显性染色,偶尔肾小球毛细血管壁也有染色。53例中有48例观察到电子致密沉积物。光镜检查显示无病变(n = 27)、局灶节段性肾小球硬化(FSGS;n = 11)、增生性肾小球肾炎(n = 20)或其他各种病变(n = 14)。组织学无病变患者的临床表现为尿常规检查正常(7%)、无症状血尿和/或蛋白尿(22%)以及肾病综合征(微小病变样病变;63%),且常复发。所有FSGS患者均表现为肾病综合征。增生性肾小球肾炎患者通常表现为慢性肾脏病(75%)或无症状尿液异常(20%)。在有足够随访数据的患者中,微小病变样病变患者77%肾病综合征完全缓解,FSGS患者33%进展至终末期肾病,增生性肾小球肾炎患者57%肾病稳定。总之,本研究确定了C1q肾病的两个主要临床病理亚组:(1)具有微小病变样病变或FSGS的足细胞病,通常表现为肾病综合征;(2)典型的免疫复合物介导的肾小球疾病,从无肾小球病变到各种形式的肾小球增生不等,通常表现为慢性肾脏病。C1q肾病的临床表现、组织学、预后以及推测的发病机制具有异质性。